Multiple myeloma (MM) is a rare type of blood cancer that often develops without early symptoms, making awareness of risk factors essential. Regional Cancer Care Associates (RCCA) provides insights on the factors that may increase a person’s likelihood of developing multiple myeloma.
With more than 20 locations across New Jersey, Connecticut, Massachusetts, and the Washington, D.C., area, RCCA is dedicated to keeping patients informed about the latest cancer research and advancements in oncology care.
Certain environmental exposures and lifestyle factors have been linked to multiple myeloma.
Several medical conditions have been associated with a higher likelihood of developing multiple myeloma.
Certain autoimmune diseases have been linked to a higher risk of myeloma, including:
A plasmacytoma is a type of plasma cell tumor that may increase the likelihood of developing multiple myeloma.
Regional Cancer Care Associates (RCCA) provides patients with the latest information on multiple myeloma and other blood cancers. With more than 20 locations across New Jersey, Connecticut, Massachusetts, and the Washington, D.C., area, RCCA remains committed to delivering expert oncology care and patient education.
To learn more about multiple myeloma risk factors or schedule a consultation, contact RCCA at 844-346-7222 or contact RCCA today.
Sources:
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Seth H. Berk, MD, says that even in this era of electronic medical records and text messaging, primary care physicians and other clinicians too often
Glen Gejerman, MD, says that when it comes to risk for developing prostate cancer and for having poor outcomes with the disease, Black men face
“My uncle’s neighbor was diagnosed with the exact same cancer, I think, last year and his specialist has been wonderful. I’m going to get you
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.
